Who owns IRWD?
Institutional ownership of Ironwood Pharmaceuticals Inc. from Form 13F, Q2 2026
212 institutional managers reported holding Ironwood Pharmaceuticals Inc. (IRWD) in Form 13F filings for Q2 2026, with 160,555,185 shares worth $676M. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 514,360 shares (+0.3%). 25 opened new positions and 36 sold out.
- Funds holding
- 212
- Value held
- $676M
- New / sold out
- 25 / 36
- Net shares, same filers
- +0.3%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of IRWD
Share of 13F holdings is each fund's shares as a share of the 160,555,185 IRWD shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$18.6M
- Mackenzie Financial Corp Added+$7.6M
- State Street Corp Added+$5.7M
- Wells Fargo & Company Added+$4.8M
- Pacer Advisors, Inc. New+$4.6M
- Morgan Stanley Added+$4.4M
- Goldman Sachs Group Inc Added+$2.6M
- HRT Financial LP New+$2.4M
- Vanguard Capital Management LLC Added+$2.2M
- Dimensional Fund Advisors LP Added+$1.9M
Biggest sellers in Q2 2026
- Charles Schwab Investment Management Inc Trimmed-$6.0M
- Susquehanna International Group, LLP Trimmed-$5.7M
- Two Sigma Investments, LP Trimmed-$5.4M
- Qube Research & Technologies Ltd Trimmed-$5.2M
- Vanguard Portfolio Management LLC Trimmed-$4.9M
- Armistice Capital, LLC Trimmed-$4.6M
- AQR Capital Management LLC Trimmed-$4.5M
- Acadian Asset Management LLC Trimmed-$3.0M
- UBS Group AG Trimmed-$2.3M
- Jane Street Group, LLC Trimmed-$2.1M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $76.4M and sold $72.6M; 72 added and 81 trimmed.
Schedule 13D and 13G filings on IRWD
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-10STATE STREET CORP SCHEDULE 13G filed by Ironwood Pharmaceuticals Inc.Schedule 13G
- 2026-08-07STATE STREET CORP SCHEDULE 13G filed by Ironwood Pharmaceuticals Inc.Schedule 13G
- 2025-11-14BANK OF AMERICA CORP /DE/ SCHEDULE 13G filed by Ironwood Pharmaceuticals Inc.Schedule 13G
- 2025-08-12BARCLAYS PLC SCHEDULE 13G filed by Ironwood Pharmaceuticals Inc.Schedule 13G
- 2025-05-13STATE STREET CORP SCHEDULE 13G filed by Ironwood Pharmaceuticals Inc.Schedule 13G
- 2025-02-05STATE STREET CORP SCHEDULE 13G filed by Ironwood Pharmaceuticals Inc.Schedule 13G
Questions about IRWD ownership
- Who owns IRWD stock?
- 212 institutional investment managers reported IRWD positions in their Form 13F filings for Q2 2026, holding 160,555,185 shares worth $676M in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling IRWD?
- In Q2 2026, 25 managers opened new IRWD positions, 72 added, 81 trimmed and 36 sold out. Managers that filed in both quarters added a net 514,360 shares.
- How current is this IRWD institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to IRWD by CUSIP. Options are left out. IRWD news and filings · IRWD insider trades · Top funds